Matthew Henn PhD
Company: Seres Therapeutics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion & Q&A 1:40 pm
day: Post-Conference Workshop Day
Microbiome Therapeutics to Transform the Treatment of Antimicrobial Resistant Infections 5:00 pm
day: Day Two
Microbiome Fireside Leaders Chat: A Forward Look 8:15 am
How do you perceive the overall role of the microbiome? How has this changed in the past 12 months? What is missing from the microbiome area of drug discovery? What are the gaps that both investors and drug developers must see, that we need to bring from other parts of biotech R&D? How is a…Read more
day: Day One